
|Articles|April 1, 2004
Metronidazole conquers EAC
Washington - Systemic metronidazole can be an effective treatment for erythema annulare centrifugum (EAC), according to Lucio Andreassi, M.D., professor and chairman of the Department of Dermatology at the University of Siena, Italy. At the annual AAD meeting, Dr. Andreassi presented a case report of a patient with a two-year history of EAC who was successfully treated with a six-week course of oral metronidazole, followed by a four-week course of topical metronidazole 1 percent gel.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
AbbVie Files for Vitiligo Indication, Putting Systemic Therapy Under Regulatory Review
2
Nutrafol Expands Portfolio with First and Only Hair Loss Supplement for Male Patients 50 and Older
3
Introducing Dermatology Times NP/PA Connect
4
Narrow-Spectrum Sarecycline Approved for Moderate to Severe Acne in China
5











